Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection |
| |
Authors: | García Felipe Lejeune Merylene Climent Nuria Gil Cristina Alcamí José Morente Vanessa Alós Llucia Ruiz Alba Setoain Javier Fumero Emilio Castro Pedro López Anna Cruceta Anna Piera Carlos Florence Eric Pereira Arturo Libois Agnes González Nuria Guilá Meritxell Caballero Miguel Lomeña Francisco Joseph Joan Miró José M Pumarola Tomás Plana Montserrat Gatell José M Gallart Teresa |
| |
Affiliation: | Infectious Diseases Unit, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clínic, University of Barcelona, Spain. fgarcia@clinic.ub.es |
| |
Abstract: | Therapeutic immunization with autologous monocyte-derived dendritic cells (DCs) loaded with heat-inactivated autologous human immunodeficiency virus type 1 (HIV-1) in 12 patients with chronic HIV-1 infection who were receiving highly active antiretroviral therapy (HAART) was feasible, safe, and well tolerated. Virus was obtained during an initial interruption of HAART (hereafter, "stop 1") so that DCs could be pulsed. After immunization and a second interruption of HAART (hereafter, "stop 2"), set-point plasma viral load (PVL; 24 weeks after stop 2) decreased > or =0.5 log(10) copies/mL relative to baseline PVL in 4 of 12 patients. We observed a significant lengthening in mean doubling time of PVL rebound and significant decreases in the area under the curve and the mean peak of PVL rebound after stop 2, compared with those after stop 1. This response was associated with changes in HIV-1-specific CD4(+) lymphoproliferative and CD8(+) T cell responses. These changes were not observed in a group of nonimmunized control patients. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|